Hepatitis C virus (HCV) viremia in human immunodeficiency virus-seronegative and -seropositive patients with indeterminate HCV recombinant immunoblot assay.
about
Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virusKASL clinical practice guidelines: management of hepatitis CDetection of hepatitis C virus by PCR in second-generation enzyme immunoassay-seropositive blood donors by using matched pairs of fresh frozen plasma and pilot tube seraDiagnosis, management, and treatment of hepatitis C: an updateDiagnosis, management, and treatment of hepatitis CCoinfection with HIV and HCV: more questions than answers?Hepatitis C and human immune deficiency coinfection at the era of highly active antiretroviral therapy.Hepatitis C and human immunodeficiency virus infection.Factors associated with seronegative chronic hepatitis C virus infection in HIV infectionEvaluation of Novel Multiplex Antibody Kit for Human Immunodeficiency Virus 1/2 and Hepatitis C Virus Using Sol-Gel Based MicroarrayManagement complexities of HIV/hepatitis C virus coinfection in the twenty-first centuryEvaluation of two rapid screening assays for detecting hepatitis C antibodies in resource-constrained settings.Effect of human immunodeficiency virus infection on hepatitis C virus infection in hemophiliacs.Stronger hepatitis C virus-specific CD8+ T-cell responses in HIV coinfection.HIV and hepatitis C coinfection within the CAESAR study.Evaluation of three rapid screening assays for detection of antibodies to hepatitis C virus.Hepatitis C is more severe in drug users with human immunodeficiency virus infection.KASL clinical practice guidelines: management of hepatitis C.
P2860
Q24240929-99C74639-6934-4CE5-9570-45AAC64F82E6Q26752471-1E9A643B-8983-4C78-A4EF-17541347F130Q27485714-6AFC8C20-AEF9-4D93-BED2-4725235EFFDAQ29619682-E4C61801-0AC9-486E-A1E9-AD2162E89CB2Q29620656-417B900C-44C2-4DFB-ADBB-1743383BC4DDQ34113786-5DF94F21-8849-4B15-8D5A-6F7204718317Q34536150-B0E50D19-9FE1-4584-A0BD-906EEEA5EF29Q34984125-D8964835-44E8-4700-A017-D46107A08725Q35206642-41FF321B-44E4-4C6C-B251-5BD5A57A05CFQ36109400-646BB332-1A67-43E2-9884-22FA6FD01EA8Q36995854-DA563D0F-DFA9-472E-B4C2-1C738FF96602Q39945743-C34CCB24-384F-44DA-9318-59750B3B6953Q42977231-6FC6D0B8-2BEB-44FD-AD8A-FE5ED19F5A14Q42997258-227B58C9-3DE1-439E-BF3C-6D1D2569E884Q44893800-9E9AE7A4-439E-4A10-89DB-8EF06F6DB121Q45364058-CC525DAA-60C2-438D-B055-1C36EE72778BQ45741645-BEE30316-5B80-4D5A-AF3C-8F4A7908F238Q51836024-A956B6E6-4440-4706-8C2D-24969747A251
P2860
Hepatitis C virus (HCV) viremia in human immunodeficiency virus-seronegative and -seropositive patients with indeterminate HCV recombinant immunoblot assay.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
Hepatitis C virus (HCV) viremi ...... recombinant immunoblot assay.
@en
type
label
Hepatitis C virus (HCV) viremi ...... recombinant immunoblot assay.
@en
prefLabel
Hepatitis C virus (HCV) viremi ...... recombinant immunoblot assay.
@en
P2093
P356
P1476
Hepatitis C virus (HCV) viremi ...... recombinant immunoblot assay.
@en
P2093
Benhamou JP
Courtois F
Erlinger S
Marcellin P
Martinot-Peignoux M
P304
P356
10.1093/INFDIS/170.2.433
P407
P577
1994-08-01T00:00:00Z